Shanghai-Based Biotech, Backed by Preeminent VCs, Seeks Chief Medical Officer

Shanghai-Based Biotech, Backed by Preeminent VCs, Seeks Chief Medical Officer

Occam Global is a strategic executive search firm with substantial experience serving entrepreneurial companies in the Healthcare and Technology sectors.

Occam has been engaged by a private, Shanghai-based, biopharmaceutical company with ambitions to become a new global player in both the established and emerging markets. The company has Sequoia Capital and Kleiner Perkins as investors, whose participation fuels the larger vision to expand through both organic discovery programs and a thoughtful business development strategy. The company has already successfully in-licensed early- and late-stage drug candidates from the top pharmaceutical companies.

The requirement is for an accomplished Chief Medical Officer, or a professional who can grow into the role, with a global presence and a proven track record in building robust early- and late-stage clinical development programs across large therapeutic indications. The role can be US- or China-based. The professional with a successful career in setting the direction for discovery and development initiatives across oncology and inflammation will enable our client to become a cornerstone biopharmaceutical company.

If you have interest in this position or know of appropriate candidates, please contact Occam’s Scientific Advisor, Christopher R. Shepard at christopher@occam-global.com.